Bayer Q3 earnings beat expectations on pharma
October 26, 2016 at 01:48 AM EDT
FRANKFURT, Oct 26 (Reuters) - Bayer, the German drugmaker that is buying U.S. seed company Monsanto, beat expectations for third-quarter earnings on gains in pharmaceuticals and forecast-beating farming pesticides.
